SEC Comment Letter 0000000000-23-013213 to UroGen Pharma Ltd. (URGN) (CIK 0001668243) (URGN)
UroGen Pharma Ltd. (URGN) (CIK 0001668243)
Date: Dec. 5, 2023 · CIK: 0001668243 · Accession: 0000000000-23-013213
AI Filing Summary & Sentiment
File numbers found in text: 001-38079
Letter
United States securities and exchange commission logo December 5, 2023 Don Kim Chief Financial Officer UroGen Pharma Ltd. 400 Alexander Park Princeton, NJ 08540 Re:UroGen Pharma Ltd. Form 10-K for Fiscal Year Ended December 31, 2022 File No. 001-38079 Dear Don Kim: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
December 5, 2023
Don Kim
Chief Financial Officer
UroGen Pharma Ltd.
400 Alexander Park
Princeton, NJ 08540
Re:UroGen Pharma Ltd.
Form 10-K for Fiscal Year Ended December 31, 2022
File No. 001-38079
Dear Don Kim:
We have completed our review of your filings. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences